Both in Blank Checks
Gesher Acquisition Corp. II vs Translational Development Acquisition
Over the past year GSHR returned +3.8% and TDAC returned +4.0%; their daily moves had a correlation of 0.08.
GSHR +3.8% TDAC +4.0%Growth of $1, one year, split-adjusted
| Metric | GSHR | TDAC |
|---|---|---|
| Price | $10.64 | $10.87 |
| Market cap | $217.6M | $209.8M |
| Today | +0.19% | +0.05% |
| 1 month | +0.5% | +0.4% |
| 6 months | — | +2.2% |
| Year to date | +3.6% | +3.6% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 37.9× |
| Price / sales | — | — |
| Net cash | — | -$1.0M |
| Dividend yield | — | — |
| Volatility (60d) | 2.5% | 2.8% |
| Short % of float | 0.0% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).